APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,897,520 | -38.6% | 1,338,000 | +47.0% | 1.08% | -28.0% |
| Q2 2023 | $82,919,220 | +38.1% | 910,200 | 0.0% | 1.50% | +27.4% |
| Q1 2023 | $60,036,792 | +4340.6% | 910,200 | +1702.9% | 1.18% | +5026.1% |
| Q1 2020 | $1,352,000 | -91.0% | 50,485 | -91.9% | 0.02% | -91.9% |
| Q3 2019 | $15,029,000 | -68.8% | 623,859 | -67.1% | 0.28% | -61.7% |
| Q2 2019 | $48,114,000 | +34.3% | 1,898,700 | +3.3% | 0.74% | +34.2% |
| Q1 2019 | $35,828,000 | +730.7% | 1,837,300 | +461.9% | 0.56% | +593.8% |
| Q4 2018 | $4,313,000 | – | 327,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |